Lexicon Pharmaceuticals, Inc.LXRXNASDAQ

Revenue (LTM)

$50M

+60.2% YoY

Net Income (LTM)

$-50M

+74.9% YoY

Free Cash Flow

$-68M

Revenue CAGR (5Y)

+15.7%

Marginsimproving

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0↓53.4%	1↑766.2%	31↑2481.5%	50↑60.2%
Gross Profit	-55	-52↑4.3%	-58↓10.3%	30↑152.7%	50↑62.6%
Operating Income	-87	-101↓15.7%	-172↓70.5%	-197↓14.8%	-49↑75.2%
Net Income	-88	-102↓16.2%	-177↓73.7%	-200↓13.1%	-50↑74.9%
EBITDA	-87	-100↓15.2%	-170↓69.7%	-184↓8.6%	-48↑73.8%
EPS Diluted	-0.61	-0.62↓1.6%	-0.80↓29.0%	-0.63↑21.3%	-0.14↑77.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	64	46↓27.7%	22↓51.5%	67↑196.7%	34↓48.5%
Total Current Assets	89	141↑58.4%	177↑25.3%	246↑39.4%	102↓58.6%
Total Assets	137	194↑41.9%	229↑18.1%	298↑30.1%	185↓38.0%
Total Current Liabilities	22	23↑4.7%	32↑36.1%	45↑43.4%	21↓53.9%
Total Liabilities	23	77↑231.0%	136↑76.6%	152↑11.8%	77↓49.2%
Total Equity	114	117↑3.1%	93↓20.5%	146↑56.8%	108↓26.3%
Total Debt	2	55↑2326.2%	106↑91.8%	108↑2.2%	62↓42.6%
Net Debt	-62	9↑114.5%	84↑834.2%	42↓50.1%	28↓33.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-87	-89↓2.1%	-162↓82.2%	-179↓10.4%	-68↑62.0%
Capital Expenditure	-1	-1↓8.6%	-0↑64.6%	-1↓119.4%	0
Free Cash Flow	-88	-90↓2.2%	-162↓80.1%	-180↓10.7%	-68↑62.3%
Stock-Based Comp	11	12↑8.9%	14↑24.5%	13↓5.9%	13↓7.3%
Net Change in Cash	-62	-18↑71.5%	-24↓34.8%	44↑285.1%	-3↓107.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance